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Dosage of the Synthetic Progestin, Norgestomet, Influences Luteinizing Hormone Pulse
Frequency and Endogenous Secretion of 17[-Estradiol in Heifers'
T. SANCHEZ, 3 M.E. WEHRMAN, F.N. KOJIMA, A.S. CUPP, E.G. BERGFELD, K.E. PETERS, V. MARISCAL,
RJ. KITOK, and J.E. KINDER 2
Department of Animal Science, University of Nebraska-Lincoln, Lincoln, Nebraska 68583-0908
ABSTRACT
The objective of this study was to determine whether there were doses at which the synthetic progestin, norgestomet, could
mimic midluteal phase concentrations of progesterone in regulating the secretion of LH and 17p-estradiol in bovine females.
Heifers were randomly assigned to one of five groups to receive: 1) one (Norg, n = 5), 2) two (2Norg, n = 5), 3) four (4Norg,
n = 5), or 4) eight (8Norg, n = 5) norgestomet implants or to serve as untreated control heifers (control, n = 5). On Day 7
(Day 0 = behavioral estrus), implants containing norgestomet were inserted, and they remained in place for 10 days. All heifers
implanted with norgestomet were treated with 25 mg prostaglandin F, (PGF2,,) on Days 7 and 8 to lyse the CL. Controls were
treated with 25 mg PGF., at the time norgestomet implants were removed from heifers of the other treatment groups. Blood
samples were collected every 15 min for 24 h on Days 10 and 16 to determine the frequency of LH pulses. Beginning 24 h after
removal of implants, samples of blood were collected at 4-h intervals for 96 h to determine the time of the preovulatory surge
of LH. Daily blood samples were collected from Day 2 to Day 48 to determine concentrations of progesterone, and samples
collected between Days 2 and 17 were used to determine concentrations of 17-estradiol. Ultrasonography was performed daily
from Day 2 until Day 23 to evaluate ovarian follicular development. Mean concentrations of LH (Days 10 and 16), frequency of
LH pulses (Days 10 and 16), and mean concentrations of 17-estradiol during the treatment period were greater (p < 0.05) in
heifers from the Norg group than in heifers from the other groups. The interval to the preovulatory surge of LH after treatment
withdrawal was longer (p < 0.05) in heifers from the 8Norg group than in heifers from the lNorg, 2Norg, and 4Norg groups.
Rate of ovarian follicular growth during the treatment period was greater (p < 0.05) in heifers from the Norg group (1.68 +0.14 mm/d) than in controls, but heifers among the other groups did not differ from controls. Size of the largest follicle on the
day before ovulation was greater (p < 0.05) in heifers treated with Norg (18.6 ± 1.2 mm) than in controls (14.8 ± 0.66 mm).
In summary, one of the doses (4Norg) of norgestomet used in the present study did mimic midluteal phase concentrations of
progesterone with respect to modulation of frequency of LH pulses, rate of ovarian follicular growth, secretion of 17,-estradiol,
time to the preovulatory surge of LH after removal of progestin, and size of the ovulatory follicle.

INTRODUCTION
Treatment with norgestomet in the presence of the CL
has been shown to result in greater pregnancy rates than
in cows and heifers treated with a norgestomet implant (6
mg) in the absence of the CL (1]. This indicated that norgestomet at the dose used to synchronize estrus does not
function like endogenous progesterone from the CL in preparing the reproductive system of bovine females for pregnancy. Treatment with norgestomet at doses (6 mg) that are
used to synchronize estrus in the Syncro-Mate-B regimen
also resulted in increased secretion of 17[-estradiol compared to that in control cows with CL [2].
Treatment of cows with one norgestomet implant induced development of persistent follicles, and treatment with
a second norgestomet implant resulted in regression of these
persistent follicles [3]. It is likely that development of persistent ovarian follicles in the absence of the CL resulted
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from the greater frequency in release of LH pulses in these
animals as compared to females with a functional CL [2].
Increasing the dose of the injectable norgestomet (6 mg)
in the Syncro-Mate-B regimen that was administered during
metestrus resulted in greater pregnancy rates than in cows
that received lower doses of injectable norgestomet [4]. It
has been reported [3, 5] that greater doses of exogenous
progesterone during synchronization of estrus decreased
endogenous 17p-estradiol and increased conception rate as
compared to the values in cows treated with lower doses
of progesterone. Circulating concentrations of progesterone indicative of luteal phase deficiency (2-3 ng/ml) resulted in increased concentrations of 173-estradiol and in
prolonged elevated concentrations of 1703-estradiol compared to those in heifers treated with greater concentrations of progesterone [6].
Luteal phase deficiency has been associated with lowered fertility in cattle [7]. Previous studies in our laboratory
[2, 61 indicated that when cows were treated with doses of
progesterone that result in circulating concentrations mimicking those of luteal phase deficiency, secretion of LH pulses
was increased and ovarian follicular development was enhanced as indicated by increased concentrations of 1713-estradiol in peripheral circulation. Treatment with greater doses
of progesterone reduced secretion of LH [6] and circulating
17{3-estradiol [2, 6].
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Our working hypothesis in the present study was that
there are doses of the synthetic progestin, norgestomet, that
mimic midluteal phase concentrations of progesterone in
regulating secretion of LH and ovarian follicular development in heifers.
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MATERIALS AND METHODS
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Animals and Experimental Design
Twenty-five beef heifers of composite breeding (1/4
Hereford, 1/4 Angus, 1/4 Pinzgauer, 1/4 Red Poll) were
used in this study (20 months of age, 337 ± 5 kg; mean +
SEM). Stage of the estrous cycle was synchronized via two
treatments with prostaglandin F2. (PGF 2,,, 25 mg; Lutalyse
Sterile Solution; Upjohn Co., Kalamazoo, MI) 11 days apart.
Heifers were randomly assigned to one of five groups to
receive: 1) one (Norg, n = 5); 2) two (2Norg, n = 5); 3)
four (4Norg, n = 5), or 4) eight (8Norg, n = 5) norgestomet implants or to serve as untreated control heifers (n
= 5).
On Day 7 of the estrous cycle (Day 0 = behavioral estrus; Day 7 = Day 0 of treatment period), the norgestomet
(6 mg/implant; Sanofi Animal Health, Inc., Overland Park,
KS) implants were inserted in the ear to remain in place
for 10 days. All heifers implanted with norgestomet were
also administered 25 mg of PGF 2,, on Days 7 and 8 to induce regression of CL. On Days 10 and 16, catheters were
inserted in the jugular vein of all heifers, and blood samples were collected every 15 min for 24 h. These samples
were used to determine frequency of LH pulses in the different treatment groups. On Day 17, norgestomet implants
were removed and control heifers were treated with PGF2U.
Starting 24 h after either removal of the implants or treatment with PGF 2a (controls), blood samples were collected
at 4-h intervals for 96 h. These samples were used to determine timing of the preovulatory surge of LH during the
follicular phase following cessation of treatment.
Blood samples collected at 15-min intervals on Days 10
and 16 were allowed to clot at room temperature and were
then stored at 4°C for 24 h. Serum was obtained after centrifugation at 1500 x g for 15 min. Serum was collected
and stored at -20°C until assayed for LH.
From all heifers, daily samples (10 ml) were collected
in tubes treated with 50 Ril of 30% EDTA (Fisher Scientific,
Fair Lawn, NJ) from Day 2 of the estrous cycle until Day 48
to determine concentrations of progesterone during treatment and during the subsequent estrous cycle. To minimize degradation of progesterone, the samples were placed
on ice immediately and the plasma was obtained by centrifugation at 1500 x g for 15 min within 1 h of collection.
Plasma samples collected from Days 7-17 were also assayed for 17[3-estradiol. Plasma samples were stored at -20°C
until assays were performed.
Concentrations of LH [8, 9] were determined by RIA Intra- and interassay coefficients of variation for the LH assays
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FIG. 1. Mean daily concentrations of progesterone during the estrous
cycle in which treatments were imposed, during the estrous cycle that ensued after cessation of treatment, and during the initial portion of the subsequent estrous cycle.

were 4.6% and 12.8%, respectively. Concentrations of progesterone [6] and 17p-estradiol [2] were determined by RIA.
Intraassay coefficients of variation for progesterone and 173estradiol were 5.3 and 3.6%, respectively; interassay coefficients of variation for progesterone and 173-estradiol were
11.5 and 13.1%, respectively.
Ovarian Follicle Evaluations
To characterize changes in size of ovarian follicles, realtime linear ultrasonography was conducted daily from Day
2 until Day 23. Ultrasonographic scanning was conducted
through use of an Equisonic LS300 Real-Time Linear Scanner with a 7.5-MHz intrarectal transducer (Tokyo Keiki LS300A; Products Group International, Boulder, CO). This allowed for measurement of ovarian follicles as small as 3
mm in diameter and for evaluation of the changes in growth
of individual follicles. Appropriate images of each ovary were
recorded daily and follicles were measured by means of a
built-in caliper system; two pictures from the sonograph of
each ovary were taken using a Sony High Contrast printer.
Rate of growth ([maximum size minus 5 mm]/number of
days) and maximum size of the dominant follicle were
measured [10].
Data Reduction and StatisticalAnalyses
Mean concentrations (ng/ml) of LH, frequency of LH
pulses (pulses/24 h), and amplitude of LH pulses (ng/ml)
were determined by the use of algorithms (Pulsar software
modified for the IBM-PC by J.F. Gitzen and V.D. Ramirez,
Univ. of Illinois, Urbana, IL). The G values used were: G(1)
= 4.25; G(2) = 3.25; G(3) = 3.00; G(4) = 2.80, and G(5)
= 2.70. The length of the luteal phase during the estrous
cycle subsequent to treatment was determined by calculating the number of days when progesterone was above 1
ng/ml of plasma during the cycle.
Pulsatile secretion of LH on Days 10 and 16 and the interval to the preovulatory surge of LH were examined by
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FIG. 2. Mean daily concentrations of 17-estradiol during the period
of treatment with various doses of norgestomet.
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RESULTS

Concentrations of progesterone during the treatment
period were greater (p < 0.05) in control heifers (6.28 +
0.42 nF/mi mean + SEM) than in those from the lNor.
0.08, 0.46 + 0.07,
2Norg, 4Norg, and 8Norg groups (0.50
0.50 + 0.08, and 0.64 + 0.07 ng/ml, respectively; Fig. 1).
Mean concentrations of 171-estradiol during the treatment
period were greater (p < 0.05) in heifers from the lNorg
group (5.19 + 0.77 pg/ml) as compared to the other groups
(1.68 + 0.28, 1.14 ± 0.15, 0.79 ± 0.13, and 1.38 ± 0.17 pg/
ml for 2Norg, 4Norg, 8Norg, and control groups, respectively; Fig. 2).
On Day 10 (Day 3 of treatment), mean concentrations of
LH were greater (p < 0.05) in heifers from the lNorg group
than in the other groups (Table 1). Frequency of LH pulses
was greater (p < 0.05) in heifers from the lNorg group
and frequency of LH pulses was suppressed (p < 0.05) in

TABLE 1. Mean concentrations of LH and frequency and amplitude of LH
pulses on Days 10 post estrus (Day 3 of treatment with norgestomet).

Group

1

Mean
concentration
(ng/ml)

Pulse
frequency
(pulses/24 h)
a

1Norg

1.99 + 0.18

2Norg

1.32+

4Norg
8Norg
Control

1.09 + 0.13 c
0.82 + 0.03'
b
1.23 + 0.22 c

0.10

b

b

Pulse
amplitude
(ng/ml)

17.4 + 1.2

1.7 -+0.28

8.4 + 1.6

2.2 -+0.40

b

bC

5.2 + 1.8
0.4 + 0.4
2.7b
8.8

2.3 + 0.71
2.7**
2.1 ±+0.38

"bCMeans with different letters within columns differ (p < 0.05)
"**Only one heifer in this group exhibited LH pulses.
'One, two, four, or eight norgestomet implants inserted on Day 7 and removed on Day 17 of the estrous cycle except for control group.
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FIG. 3. Frequency of LH pulses from representative heifers treated with
various doses of norgestomet on Day 10 (Day 10 = Day 3 of treatment
period) and on Day 16 (Day 16 = Day 9 of treatment period).
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TABLE 2. Mean concentrations of LH and frequency and amplitude of LH
pulses on Days 16 post estrus (Days 9 of treatment with norgestomet).

Group'

Mean
concentration
(ng/ml)

1Norg
2Norg
4Norg
8Norg
Control

1.97 ± 0.24 a
0.54 ±+0.05 C
0.68 + 0.10 c
0.83 -+ 0.12
1.53
0.11 b

Pulse
amplitude
(ng/ml)

Pulse
frequency
(pulses/24 h)
19.6
14.0
8.0
5.2
14.4

a

± 0.6

+ 1.7 b
c
± 4.6
+ 2.7 c
1.9b

1.63
0.75
1.27
1.97
1.96

+ 0.42
+ 0.10 b
+ 0.11 a
+ 0.30 a
+ 0.31 a

'bCMeans with different letters within columns differ (p < 0.05)
'One, two, four, or eight norgestomet implants inserted on Day 7 and removed on Day 17 of the estrous cycle except for control group.

heifers of the 8Norg group as compared to heifers from
the lNorg, 2Norg, and control groups. Frequency of LH
pulses did not differ in heifers of the 2Norg, 4Norg, and
control groups. Amplitude of LH pulses did not differ (p
> 0.05) among heifers from the lNorg, 2Norg, 4Norg, and
control groups; however, only one heifer in the 8Norg group
had any pulses of LH, and this heifer had two pulses (Table
1). Data for representative heifers of each group are depicted for individual heifers in Figure 3.
On Day 16 (Day 9 of treatment), mean concentrations of
LH and frequency of LH pulses were greater (p < 0.05) in
heifers treated with Norg compared to controls and compared to heifers from the other groups treated with norgestomet (Table 2). Frequency of LH pulses was greater in
heifers from the Norg group than in those of any other
group. Frequency of LH pulses did not differ (p > 0.10)
among the 2Norg and control groups and was lowest (p <
0.05) in heifers from the 4Norg and 8Norg groups (Table
2). Amplitude of LH pulses was lowest (p < 0.05) in heifers
from the 2Norg group but did not differ (p > 0.10) among
heifers from the other four groups (Table 2).
The interval to the preovulatory surge of LH was longer
in heifers from the 8Norg group (92.0 + 10.7 h) than in
those from any other treatment group (Table 3). Rate of
growth of the dominant ovarian follicle was greater (p <
0.05) in heifers from the lNorg group than in those from
the other groups, but did not differ among heifers in the
other four groups (Table 4). Mean size of the ovarian follicle the day before ovulation was greater (p < 0.05) in
TABLE 3. Time to preovulatory surge of LH (hours after implant removal
or treatment with PGF 2. in controls) and luteal phase length of the subsequent estrous cycle.
Group'

LH surge
(hours)

Luteal phase length
(days)
b

1Norg
2Norg

50.8+
46.4+

4Norg

65.0

8Norg
Control

92.0 + 10.7
ab
66.0+ 13.1

15.4
b
3.2

3.0 b
a

14.4 + 1.53a
ab
12.0
0.84

11.8+

1.06 ab

9.2 + 2 .5 5b
ab
13.0 + 0.5 5

abCMeans with different letters within column differ (p < 0.05)
'One, two, four, or eight norgestomet implants inserted on Day 7 and removed on Day 17 of the estrous cycle except for control group.

TABLE 4. Rate of ovarian follicle growth and size of dominant follicle the
day before ovulation.
Group'

Rate of growth
(mm/d)

1Norg
2Norg
4Norg
8Norg
Control

1.68 + 0.040
1.20
0.04 b
1.07 + 0.0 5 b
1.00
0.12 b
1.12 + 0.06 b

Size of dominant
follicle (mm)
18.6
17.0
15.2
16.7
14.8

+ 1.2a
1.0ab
+ 0 .6b
+ 0.8 b
b
± 0.7

-

abeMeans with different letters within column differ (p < 0.05)
T
One, two, four, or eight norgestomet implants inserted on Day 7 and removed on Day 17 of the estrous cycle except for control group.

heifers from the Norg group than that of 4Norg and control heifers (Table 4). Duration of the luteal phase during
the estrous cycle subsequent to the period of treatment did
not differ (p > 0.10) among heifers from the five groups.
DISCUSSION

Frequency of LH pulses on Day 10 (Day 3 of treatment)
in heifers from the 2Norg, 4Norg, and control groups agree
with those previously reported [14] for cows during the
midluteal phase of the estrous cycle. Data for frequency of
LH pulses of heifers from the lNorg group agree with data
for cows treated with the Syncro-Mate-B regimen for synchronization of estrus [2] and for heifers receiving doses of
progesterone that resulted in circulating concentrations of
1 to 2 ng/ml of progesterone in plasma [6]. Profiles of LH
secretion in heifers of the lNorg group are similar to those
detected during the follicular phase of the estrous cycle of
bovine females [15]. Therefore, the dose (6 mg) of norgestomet used commercially to synchronize estrus does not
mimic concentrations of progesterone during the midluteal
phase of the estrous cycle in modulating the frequency of
LH pulses. In heifers from the 8Norg group, there was a
greater suppression of release of LH pulses than in controls. Only one heifer treated with 8Norg exhibited LH pulses
on Day 10, and this animal had only two pulses/24 h.
Frequency of release of LH pulses on Day 16 (Day 9 of
treatment) was greater than on Day 10 (Day 3 of treatment).
This is in agreement with previous work showing that frequency of LH pulses fluctuated depending upon the relative
concentration of gonadal steroids in circulation [14]. Onset
of luteolysis had started in most controls, explaining the
increased frequency of LH pulses due to decreased circulating progesterone on Day 16 in these heifers. Heifers in
all the groups treated with norgestomet had an increased
frequency of LH pulses as the duration of treatment with
norgestomet progressed. This might indicate that the rate
of norgestomet release from the implants was reduced to
levels that did not inhibit pulsatile secretion of LH to the
same degree as earlier in the treatment period. It is likely
that this decreased release of norgestomet resulted from
depletion of norgestomet from the implants.
Timing of the preovulatory surge of LH occurred about
50 h after cessation of treatment in heifers receiving Norg
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or 2Norg; it occurred 65-66 h after cessation of treatment
in heifers from the 4Norg group or after treatment with
PGF2, in controls. Preovulatory surges occurred about 92
h after cessation of treatment in heifers given 8Norg. This
indicates that ovarian follicular development might have been
inhibited to a greater degree in heifers treated with 8Norg
than in those of the other groups. Treatment with the greater
doses of norgestomet suppressed secretion of 171-estradiol
below the concentrations present at initiation of treatment.
It is likely that this was due to the lowered frequency of
LH pulses, particularly in heifers treated with 8Norg. It has
been reported [16] that a negative correlation exists between relative size of the preovulatory follicle after the decline of progesterone and the interval from the decline in
progesterone to the preovulatory LH surge. Alternatively,
treatment with 8Norg might have resulted in more residual
norgestomet for longer periods after treatment withdrawal
in this group than in the others. This might have led to the
longer period from norgestomet withdrawal to onset of the
preovulatory surge of gonadotropins in heifers of this group.
Mean circulating concentration of 1713-estradiol did not
differ among treatment groups at the beginning of the treatment. Lower concentrations of 17-estradiol were maintained in control heifers and heifers treated with 2Norg,
4Norg, and 8Norg than in heifers from the lNorg group
throughout the treatment period. By Day 9, greater concentrations of 1713-estradiol were present in the circulation
of heifers receiving lNorg, and these concentrations remained above those of heifers in the other groups for the
remainder of the treatment period. There appeared to be
increased circulating concentrations of 17-estradiol at the
end of the treatment period in heifers given 2Norg. In addition, treatment with 4Norg or 8Norg appeared to suppress circulating concentrations of 1713-estradiol during the
earlier portion of the treatment period.
According to previous reports, cows treated with norgestomet have elevated circulating concentrations of 173estradiol that are associated with increased size of the largest follicle [17]. In the present experiment, rate of growth
and size of the dominant ovarian follicle were greatest in
heifers treated with Norg, and this resulted in the greater
173-estradiol concentrations in these heifers.
Recent research has indicated that slight increases in LH
pulse frequency promoted prolonged ovarian follicular
growth and dominance associated with increased concentrations of 171-estradiol plasma [18]. This suggests that the
demise of nonovulatory dominant follicles during the typical estrous cycle occurs through feedback effects of luteal
progesterone on secretion of LH.
Previous research from our laboratory [1] indicated that
there were increased concentrations of 173-estradiol over
extended periods of time in cows and heifers treated with
norgestomet in the absence of a CL as compared to cows
and heifers treated with norgestomet in the presence of a
CL. In addition, cows with low circulating concentrations of

progesterone have elevated concentrations of 171-estradiol, and prolonged exposure to elevated concentrations of
173-estradiol may alter the cascade of endocrine and physiological events required to establish or maintain pregnancy in cattle [5]. A corresponding decrease in pregnancy
rate occurred in animals treated with norgestomet in the
absence of the CL compared to those with the CL present
[1]. This suggested that the greater concentrations of 1713estradiol may be altering the oocyte, rendering it defective
or incapable of being fertilized [19], or that the increase in
171-estradiol over extended periods of time may adversely
affect the uterine or oviductal environment to make it hostile for the developing embryo [20].
In summary, there is variation in the pattern of release
of LH that is related to the dose of norgestomet, and this
in turn affects circulating concentrations of 1713-estradiol as
well as duration in time to onset of behavioral estrus and
ovulation after implant removal. The rate of growth and size
of dominant ovarian ovulatory follicles also vary depending
on the dose of norgestomet; however, there was no difference in the duration of the luteal phase among heifers of
the different groups during the estrous cycle subsequent to
treatment. There are doses at which the synthetic progestin
norgestomet can be used to mimic the function of CL in
modulating secretion of LH and 1713-estradiol. Doses of
norgestomet that modulate the secretion of LH and 1713estradiol in a manner similar to progesterone from the
midluteal phase CL may vary depending on the size of bovine females. For example, the numbers of norgestomet
implants that were effective in mimicking CL function in
heifers in the present study may not be effective in mature
cows. Implants designed to release norgestomet at concentrations that mimic luteal function in the modulation of LH
and 173-estradiol may result in greater pregnancy rates if
used in programs of estrous cycle control in bovine females.
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